Biotechnology
Brazilian companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Biomarin Pharmaceutical Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh ranks as the top gainer, and Moderna, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.